v3.26.3
Condensed Statement of Cash Flows (Unaudited)
 5 Months Ended
Sep. 30, 2026
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (33,105)
Adjustments to reconcile net loss to net cash used in operating activities:  
Payment of formation, general and administrative expenses through issuance of ordinary shares 25,000
Payment of operating expenses through promissory note – related party 6,744
Share-based compensation expense 38,806
Interest earned on investments held in Trust Account (233,988)
Changes in operating assets and liabilities:  
Prepaid expenses (137,246)
Long-term prepaid insurance (113,753)
Accounts payable and accrued expenses 58,332
Deferred legal fees 20,352
Net cash used in operating activities (368,858)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (69,000,000)
Net cash used in investing activities (69,000,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Public Shares, net of underwriting discounts paid 68,310,000
Proceeds from sale of private placement shares 2,340,000
Underwriters’ reimbursement 172,500
Proceeds from promissory note – related party
Repayment of promissory note – related party (40,623)
Payment of offering costs (367,000)
Net cash provided by financing activities 70,414,877
Net Change in Cash 1,046,019
Cash – Beginning of period
Cash – End of period 1,046,019
Non-cash investing and financing activities:  
Offering costs included in accrued offering costs 342,000
Offering costs paid through promissory note - related party 33,879
Deferred underwriting fee payable $ 2,070,000